Walters Group's Form 4 filing
Zentalis Pharmaceuticals, Inc. (ZNTL) · filed Jan 8, 2026
- Accession no.
- 0001213900-26-002567
- Filed
- Jan 8, 2026, 4:57 PM ET
- Trade date
- Dec 31, 2025
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $7.75M. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Walters GroupCIK 0001177523 | 10% Owner |
| Walters William ThurmanCIK 0001689655 | 10% Owner |
| Walters Susan BerkleyCIK 0001689761 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Common Stock | PPurchaseAcquired | +6,459,973 | $1.20 | +$7,751,967.6 | 13,509,973 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.